Cardinal Health Inc. ($CAH) Stock Forecast: Up 13.0% Today

What is Cardinal Health Inc.?

Cardinal Health Inc. (NYSE: CAH) operates in the healthcare services sector, offering pharmaceutical and medical products to healthcare providers. The company has recently displayed robust performance in the market.

Why is Cardinal Health Inc. going up?

CAH stock is up 13.0% on Oct 30, 2025 16:42

• The stock of Cardinal Health saw a notable increase following the positive announcement of its first-quarter 2026 earnings. Adjusted earnings outperformed expectations, and sales witnessed a substantial year-over-year growth.
• Cardinal Health's successful performance in Q1 and the upgraded 2026 EPS forecast point towards a widespread expansion and growing profitability across all sectors, fostering investor confidence.
• Investor optimism towards Cardinal Health has been influenced by its consistent market outperformance in the last 5 years, indicating attractive returns for stakeholders.
• Anticipated double-digit revenue growth in the first quarter of fiscal year 2026, especially in the Pharmaceutical and Specialty units, has further heightened investor confidence in the company's future prospects, encouraging a bullish trend in the stock price.

CAH Price Chart

CAH Technical Analysis

CAH News

Cardinal Health Rallies As Strong Start To 2026 Fuels Higher Earnings Guidance Cardinal Health's Strong Start To 2026 Fuels Higher Earnings Guidance - Cardinal Health ( NYSE:CAH )

Cardinal Health Inc.'s ( NYSE:CAH ) stock surged on Thursday as the healthcare services company reported upbeat first-quarter 2026 earnings, with adjusted earnings of $2.55 per share, beating the consensus of $2.18. Sales increased 22% year over year to $64.01 billion, surpassing the ...

https://www.benzinga.com/markets/earnings/25/10/48535297/cardinal-health-rallies-as-strong-start-to-2026-fuels-higher-earnings-guidance

CAH Q1 Earnings Beat Estimates, '26 EPS View Up, Stock Gains

Cardinal Health delivered a strong Q1 beat and lifted its 2026 EPS outlook, fueled by broad-based growth and rising profits across all business segments.

https://www.zacks.com/stock/news/2781669/cah-q1-earnings-beat-estimates-26-eps-view-up-stock-gains

Cardinal Health ( CAH ) Laps the Stock Market: Here's Why

In the closing of the recent trading day, Cardinal Health (CAH) stood at $161.89, denoting a +1.72% move from the preceding trading day.

https://www.zacks.com/stock/news/2776833/cardinal-health-cah-laps-the-stock-market-heres-why

Here's How Much $100 Invested In Cardinal Health 5 Years Ago Would Be Worth Today - Cardinal Health ( NYSE:CAH )

Cardinal Health ( NYSE:CAH ) has outperformed the market over the past 5 years by 12.91% on an annualized basis producing an average annual return of 27.8%. Currently, Cardinal Health has a market capitalization of $38.46 billion.

https://www.benzinga.com/insights/news/25/10/48418872/heres-how-much-100-invested-in-cardinal-health-5-years-ago-would-be-worth-today

Pharma, Specialty Units Likely to Drive Cardinal Health's Q1 Earnings

CAH's Pharmaceutical and Specialty units are expected to have fueled double-digit revenue growth in Q1 FY26 despite tariff and cost headwinds.

https://www.zacks.com/stock/news/2776179/pharma-specialty-units-likely-to-drive-cardinal-healths-q1-earnings

Trending Today

ZCash ($ZEC) Crypto Forecast: Down 13.5% Today

Ethereum ($ETH) Crypto Forecast: Up 5.1% Today

Cardinal Health Inc. Price History

31.00.2025 - CAH Stock was down 5.4%

• CAH reported strong Q2 earnings and sales that exceeded expectations, with an increase in the 2025 EPS view. Still, the negative impact of the OptumRx contract expiry on Pharmaceutical segment sales likely contributed to the bearish movement.
• The news of a Congress member buying up to $15K in Cardinal Health stock may have added some uncertainty or negative sentiment to the market, influencing the stock's downward trend.
• Despite solid revenue growth in the Other segment and increased sales in branded and specialty pharmaceuticals, concerns about the OptumRx contract expiry and supply-chain challenges may have overshadowed positive developments.
• Investors may approach Cardinal Health cautiously due to recent events and uncertainties surrounding the company's key segments and contracts.

06.00.2025 - CAH Stock was down 1.3%

• Despite CAH's strong quarterly results and robust product portfolio, the stock experienced a -1.02% decline in the most recent trading session.
• The market movement could be attributed to profit-taking by investors after a period of growth, leading to a temporary dip in the stock price.
• Investors might be reacting to broader market trends or sector-specific news impacting healthcare companies, causing a negative sentiment towards CAH in today's trading.

30.00.2025 - CAH Stock was up 0.0%

• The positive anticipation surrounding its upcoming Q2 earnings report, with growth in branded and specialty pharmaceutical sales expected to drive performance, could be a factor in the recent bullish movement in CAH.
• Market sentiment might have been influenced by a Congress member's purchase of Cardinal Health stock, signaling confidence in the company's future prospects.
• Contributing to the upward momentum in CAH's stock price could be the overall bullish trend in the market and the company hitting a 52-week high.

04.03.2025 - CAH Stock was down 5.6%

• CAH stock fell by 1.14% in the latest trading session.
• This downward movement could be related to market volatility or negative factors affecting the healthcare industry.
• Investors may be responding to worries about regulatory adjustments or changes in consumer healthcare demands.
• Traders should stay updated on company-specific updates and broader market patterns when considering CAH's stock.

11.11.2024 - CAH Stock was down 1.4%

• The strength in CAH's pharmaceutical segment and diversified product portfolio was not enough to counterbalance the challenges of concentrated revenue generation and regulatory setbacks.
• Concerns about concentrated revenue generation and regulatory setbacks seemed to heavily influence investor sentiment, causing a decline in CAH's stock.
• Despite the positive aspects of the company's business segments, challenges mentioned earlier seemed to overshadow potential gains, resulting in today's bearish market movement for CAH.

03.09.2025 - CAH Stock was down 3.7%

• Cardinal Health (CAH) may have faced a downward trend due to its underperformance relative to other medical stocks like Arcutis Biotherapeutics (ARQT).
• The subdued performance of CAH in the healthcare industry this year might be linked to the market's negative movement.
• Investors could be turning their attention towards more promising opportunities in the medical field, resulting in a sell-off of CAH shares.
• Contrasting with ARQT's strong showing could have revealed weaknesses in CAH's finances or growth prospects, prompting investors to review their positions and contributing to the bearish trend.

12.07.2025 - CAH Stock was down 7.3%

• There has been bullish options activity indicating positive sentiment from investors, although this did not result in a positive stock movement.
• The company exceeded earnings estimates and raised EPS guidance for 2026, leading to a stock drop potentially linked to concerns about the expiration of the OptumRx contract and its impact on Pharmaceutical segment sales.
• The upcoming release of Q4 earnings may have caused stock price volatility as investors reacted to forecast changes and dividend income strategies.
• A comparison with Adaptive Biotechnologies in the medical sector suggests that market dynamics and company-specific factors could have influenced Cardinal Health's bearish performance despite positive developments.

12.07.2025 - CAH Stock was down 12.2%

• The bearish movement in CAH stock could be attributed to investors' concerns about the upcoming earnings report falling short of expectations.
• Discussion about earning $500 a month from CAH stock might have raised unrealistic expectations among investors, leading to disappointment when the stock did not perform as anticipated.
• A comparison with Adaptive Biotechnologies (ADPT) might have highlighted stronger performance in the medical sector by ADPT, causing some investors to shift their focus away from CAH.
• Overall, the bearish movement in CAH could be a result of a combination of profit-taking, cautious investor sentiment ahead of the earnings report, and comparative underperformance within the sector.

10.05.2025 - CAH Stock was down 0.5%

• The overall market sentiment is bearish today.
• The bearish movement in CAH stock could be attributed to the announcement of a distribution services agreement between Citius Pharmaceuticals and Cardinal Health. This partnership might have raised concerns among investors about potential competition or changes in Cardinal Health's business strategy, leading to a negative impact on CAH stock price.

30.09.2025 - CAH Stock was up 17.6%

• Cardinal Health (CAH) saw a solid uptrend today, with its stock price rising by +1.72%.
• The positive market sentiment towards CAH is driven by expectations of robust Q1 earnings, especially in its Pharmaceutical and Specialty units.
• CAH has consistently outperformed the market over the past 5 years, with an average annual return of 27.8%, attracting investors seeking stable returns in the healthcare sector.
• The favorable expectations for CAH's financial performance and its strong position in the healthcare industry have fueled the uptick in its stock price today.

30.09.2025 - CAH Stock was up 17.4%

• Cardinal Health (CAH) experienced a strong bullish movement today, with its stock price increasing by +1.72%.
• The positive market movement can be attributed to the expectation of double-digit revenue growth in Q1 FY26, primarily driven by the Pharmaceutical and Specialty units.
• Additionally, the company's consistent outperformance in the market over the past 5 years, with an average annual return of 27.8%, has likely contributed to investor confidence and buying interest in CAH shares.
• Overall, the market seems optimistic about Cardinal Health's future prospects, supported by strong financial performance and growth potential in key business segments.

30.09.2025 - CAH Stock was up 13.0%

• The stock of Cardinal Health saw a notable increase following the positive announcement of its first-quarter 2026 earnings. Adjusted earnings outperformed expectations, and sales witnessed a substantial year-over-year growth.
• Cardinal Health's successful performance in Q1 and the upgraded 2026 EPS forecast point towards a widespread expansion and growing profitability across all sectors, fostering investor confidence.
• Investor optimism towards Cardinal Health has been influenced by its consistent market outperformance in the last 5 years, indicating attractive returns for stakeholders.
• Anticipated double-digit revenue growth in the first quarter of fiscal year 2026, especially in the Pharmaceutical and Specialty units, has further heightened investor confidence in the company's future prospects, encouraging a bullish trend in the stock price.